Skip to main content
. 2021 Jan 15;2021(1):CD013198. doi: 10.1002/14651858.CD013198.pub2
Author Class/antibiotic Dose COPD severity Duration of treatment Risk of bias
Brill 2015
(N = 99);
UK (1 outpatient
hospital department)
  • Quinolone/Moxifloxacin

  • Tetracycline/Doxycycline

  • Macrolide/Azithromycin

  • 400 mg daily for 5 days every 4 weeks (pulsed)

  • 100 mg daily (continuous)

  • 250 mg three times per week (intermittent)

Moderate to severe
FEV₁ 1.4 L
13 weeks Unclear performance
bias;
detection bias
judged as high